AeroMed Technologies’ Innovative COVID-19 and Airborne Infection Control Solutions at 7 Top Hospitals

AeroMed Technologies’ infectious disease solutions appear in a number of top hospitals and healthcare facilities throughout the United States and internationally thanks to their proven track record. From New York to California to India, these clients include:

  • Kings County Hospital – Brooklyn, NY
  • Coney Island Hospital – Brooklyn, NY
  • Bellevue Hospital – Manhattan, NY
  • National Institute of Tuberculosis and Respiratory Disease – New Delhi, India
  • NYC Health + Hospitals Corporation (HHC) – New York, NY
  • Hospital for Special Surgery (HSS) – New York, NY
  • Los Angeles County Department of Public Health – California

AeroMed Technologies solutions are comprised of either HEPA filtration-based air purifiers or upper-room germicidal ultraviolet (GUV) lights. According to Palmer, client solutions are customized based on the unique configuration of the hospital or healthcare facility and its specific needs.

“The goal of both systems is to reduce the risk of infection by diluting the concentration of viable microbes in the air, whether they’re viruses or bacteria,” Palmer explains. “GUV lights reduce the concentration of viable pathogens by inactivating microbes in the air – it doesn’t remove them but disinfects them so they can no longer cause infection. HEPA filtration relies on moving air through a series of filters to physically remove those same microbes from the air. We are often able to combine both HEPA filtration and GUV into the same product. This protects both the room occupant and the person who eventually will service the air purifier.”

Upper-room GUV lights are a crucial, cost-effective product in the fight against COVID-19 and have been provided to clients by AeroMed for the past 10 years for airborne infectious disease applications around the world.

AeroMed Technologies’ upper-room GUV lights are thoroughly tested and vetted by an independent laboratory for performance. This technology is recommended by the Centers for Disease Control and Prevention (CDC) for COVID-19 applications, stating that upper-room UVG lights “can be used to provide air cleaning within occupied spaces.”

“Our solutions not only provide healthcare professionals peace of mind about working in at-risk settings, but they also create a sense of safety for patients and visitors,” says Palmer. “Some local hospitals, for example, are showing their infection control equipment in advertising to show that they’re taking action to reduce the risk to their patients and employees.”

AeroMed Technologies brings over 30-years’ experience providing such infectious pathogen solutions to the healthcare industry – long before the COVID-19 outbreak began. Its representatives work with experts around the world to ensure their upper-room GUV light and HEPA filtration systems are properly deployed to reduce the risk of airborne infection. During installation, AeroMed Technologies conducts further testing to ensure that the GUV lights, once installed, are effective against pathogens and safe for room occupants.

“We have a proven track record of applying these technologies before most others currently serving the industry and take pride in our effective systems, which are applied based on the unique requirements of each facility,” says Palmer. “Hospitals and healthcare providers can trust AeroMed Technologies to perform a risk assessment, recommend the most viable solutions for their needs, and implement the technology correctly to reduce risk in their facility.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”